Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world safety and effectiveness of dapagliflozin in people living with type 1 diabetes in Spain: The Dapa-ON multicenter retrospective study.
Durán-Martínez M, Azriel S, Doulatram-Gamgaram VK, Moreno-Pérez Ó, Pinés-Corrales PJ, Tejera-Pérez C, Merino-Torres JF, Brito-Sanfiel M, Chico A, Marco A, García-Fernández E, Martínez-Montoro JI; Diabetes Area of the Spanish Society of Endocrinology and Nutrition (SEEN). Durán-Martínez M, et al. Among authors: brito sanfiel m. Diabetes Metab. 2024 Jan;50(1):101501. doi: 10.1016/j.diabet.2023.101501. Epub 2023 Dec 5. Diabetes Metab. 2024. PMID: 38061425 Free article.
Clinical and metabolic profile of patients with latent autoimmune diabetes in adults in specialized care in Madrid.
Arranz Martín A, Lecumberri Pascual E, Brito Sanfiel MÁ, Andía Melero V, Nattero Chavez L, Sánchez López I, Cánovas Molina G, Arrieta Blanco F, González Perez Del Villar N; Grupo de Diabetes de la Sociedad de Endocrinología, Nutrición y Diabetes de Madrid (SENDIMAD). Arranz Martín A, et al. Endocrinol Diabetes Nutr. 2017 Jan;64(1):34-39. doi: 10.1016/j.endinu.2016.09.001. Epub 2017 Jan 19. Endocrinol Diabetes Nutr. 2017. PMID: 28440768 English, Spanish.
Practical Approach to Initiating SGLT2 Inhibitors in Type 2 Diabetes.
Gomez-Peralta F, Abreu C, Lecube A, Bellido D, Soto A, Morales C, Brito-Sanfiel M, Umpierrez G. Gomez-Peralta F, et al. Among authors: brito sanfiel m. Diabetes Ther. 2017 Oct;8(5):953-962. doi: 10.1007/s13300-017-0277-0. Epub 2017 Jul 18. Diabetes Ther. 2017. PMID: 28721687 Free PMC article. Review.
Erratum to: Practical Approach to Initiating SGLT2 Inhibitors in Type 2 Diabetes.
Gomez-Peralta F, Abreu C, Lecube A, Bellido D, Soto A, Morales C, Brito-Sanfiel M, Umpierrez G. Gomez-Peralta F, et al. Among authors: brito sanfiel m. Diabetes Ther. 2017 Oct;8(5):963-965. doi: 10.1007/s13300-017-0290-3. Diabetes Ther. 2017. PMID: 28836177 Free PMC article. No abstract available.
Effectiveness and Tolerability of the Intensification of Canagliflozin Dose from 100 mg to 300 mg Daily in Patients with Type 2 Diabetes in Real Life: The INTENSIFY Study.
Gorgojo-Martinez JJ, Ferreira-Ocampo PJ, Galdón Sanz-Pastor A, Cárdenas-Salas J, Antón-Bravo T, Brito-Sanfiel M, Almodóvar-Ruiz F. Gorgojo-Martinez JJ, et al. Among authors: brito sanfiel m. J Clin Med. 2023 Jun 25;12(13):4248. doi: 10.3390/jcm12134248. J Clin Med. 2023. PMID: 37445283 Free PMC article.
16 results